Drug Page

Ed Silverman at STAT reports that Congress has linked increased research funding to “fast-track” approval procedures. “By linking the extra funds to speedier approvals,...

James Davies, of the Council for Evidence-Based Psychiatry, issues his report from last week’s meeting in the UK Parliament concerning the connection between increased...

A new article in The Medical Journal of Australia laments that, while antidepressant use continues to climb, the research evidence shows that their effectiveness...

ProPublica and The Washington Post have performed an investigation revealing that Medicare has failed to monitor the safety of the large quantities of drugs...

Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.

In the past six years, I have had the opportunity to speak at several conferences or meetings that I felt had particular potential to stir some political activity that would challenge current psychiatric practices, and one of those events was the meeting convened in the U.K.’s Parliament on May 11th, which had this title for the day: Rising Prescriptions, Rising Mental Health Disability: Is There a Link?

When the CDC released data revealing an increasing suicide rate in the US, some experts, speaking to major media outlets, speculated that the increase...

According to a new STAT-Harvard poll, the majority of Americans oppose new legislation that would speed up the approval of new drugs and medical...

The US FDA has issued a new warning for the atypical antipsychotic Olanzapine, also known by the brand names Zyprexa and Symbyax. The agency...

The All-Party Parliamentary Group for Prescribed Drug Dependence is meeting today, May 11th, to discuss evidence of the link between the rise in disability...

In my wildest dreams, I could never have imagined being drawn into a story of intrigue involving my own government’s efforts to hide, from the public, reports of psychiatric drugs associated with cases of murder, including homicides committed by youth on the drugs. But that is precisely the intrigue I now find myself enmeshed in.

The Centers for Disease Control and Prevention (CDC) released new data indicating that as many as 75% of young children who are diagnosed with...

Yesterday, the US Food and Drug Administration (FDA) released a warning that the antipsychotic drug aripiprazole or Abilify is associated with compulsive and uncontrollable...

Mindfulness-based cognitive therapy (MBCT) may be more effective at reducing the risk of depressive relapse compared to current standard treatments with antidepressant drugs. A...

Nick Harrop, a campaign manager at YoungMinds, supporting young people’s mental health and wellbeing, said antidepressants for children should never be the only course of action....

A new review finds that mindfulness-based cognitive therapy (MBCT) can help stave off recurring depression as effectively as antidepressants. People suffering from depression who...

While clinical trials make up the “bedrock of evidence-based medicine” in other specialties, psychiatry faces a number of both ethical and scientific problems related to its use of randomized control trials. According to a new editorial in The Lancet Psychiatry, the field of psychiatry research has particular problems with ethical issues in recruitment, inaccurate classification systems, and controversial placebo comparisons, and then, once the studies are finished, it often remains unclear what the “outcomes actually mean for people’s lives.”

For the New York Times, Cornell psychiatrist Richard Friedman proposes new regulations to make direct-to-consumer drug ads reveal the relative price and effectiveness information that...

Multiple media sources are reporting on new data from the CDC revealing a substantial increase in the suicide rate in the United States between 1999...

A study, comparing the effects of antidepressants combined with psychotherapy for severe depression to antidepressants alone, has been retracted and replaced by JAMA Psychiatry....

The Mercury News reports that California’s judicial council is taking major steps to address the rampant use of psychiatric drugs in foster care. The...

A new study, published in JAMA Neurology, found that older people who regularly took anticholinergic drugs, including certain cold medicines or antidepressants, had poorer...

The U.S. Preventive Services Task Force (USPSTF) recently issued a controversial recommendation that all adolescent and adult patients undergo depression screening in primary care. The...

A new study finds that prenatal exposure to antidepressant drugs, known as selective serotonin reuptake inhibitors or SSRIs, is associated with higher rates of...

New data reveals that the majority of care homes in British Columbia, Canada are giving out prescriptions for antidepressants and antipsychotics without a diagnosis....